A different kind of episode: Harry answers listener questions directly, sharing his own perspective on AI, data and where healthcare and life sciences are heading.

Harvard’s Isaac Kohane on evaluating large language models in medicine, why a human-in-the-loop remains essential, and how adoption could shift from optional to a question of liability.

GRO Biosciences on building therapies from non-standard amino acids — the building blocks outside biology’s usual set of 20 — to improve protein stability, delivery and drug durability.

One Health Company co-founder Christina Kelly Lopes on FidoCure, precision cancer treatment for dogs, and why naturally occurring canine cancer is a powerful window into the human disease.